<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Berek K</submitter><funding>Tiroler Wissenschaftsförderung</funding><pagination>e70165</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11570677</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(11)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Neurological symptoms are common in acute mountain sickness (AMS); however, the extent of neuroaxonal damage remains unclear. Neurofilament light chain (NfL) is an established blood biomarker for neuroaxonal damage.&lt;h4>Objective&lt;/h4>To investigate whether plasma (p) NfL levels increase after simulated altitude exposure, correlate with the occurrence of AMS, and might be mitigated by preacclimatization.&lt;h4>Methods&lt;/h4>Healthy subjects were exposed to simulated high altitude (4500 m) by the use of a normobaric hypoxic chamber at the University of Innsbruck two times, that is, within Cycle 1 (C1) over 12 h, and within Cycle 2 (C2) for another 12 h but with a random assignment to prior acclimatization or sham acclimatization. Before each cycle (measurement [M] 1 and 3) and a</pubmed_abstract><journal>Brain and behavior</journal><pubmed_title>Neurofilament Light Chain Is Associated With Acute Mountain Sickness.</pubmed_title><pmcid>PMC11570677</pmcid><funding_grant_id>F430.68</funding_grant_id><pubmed_authors>Bsteh G</pubmed_authors><pubmed_authors>Berek K</pubmed_authors><pubmed_authors>Hegen H</pubmed_authors><pubmed_authors>Wille M</pubmed_authors><pubmed_authors>Burtscher M</pubmed_authors><pubmed_authors>Lindner A</pubmed_authors><pubmed_authors>Ponleitner M</pubmed_authors><pubmed_authors>Deisenhammer F</pubmed_authors><pubmed_authors>Engler C</pubmed_authors><pubmed_authors>Pauli FD</pubmed_authors><pubmed_authors>Treml B</pubmed_authors><pubmed_authors>Kleinsasser A</pubmed_authors><pubmed_authors>Berger T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neurofilament Light Chain Is Associated With Acute Mountain Sickness.</name><description>&lt;h4>Background&lt;/h4>Neurological symptoms are common in acute mountain sickness (AMS); however, the extent of neuroaxonal damage remains unclear. Neurofilament light chain (NfL) is an established blood biomarker for neuroaxonal damage.&lt;h4>Objective&lt;/h4>To investigate whether plasma (p) NfL levels increase after simulated altitude exposure, correlate with the occurrence of AMS, and might be mitigated by preacclimatization.&lt;h4>Methods&lt;/h4>Healthy subjects were exposed to simulated high altitude (4500 m) by the use of a normobaric hypoxic chamber at the University of Innsbruck two times, that is, within Cycle 1 (C1) over 12 h, and within Cycle 2 (C2) for another 12 h but with a random assignment to prior acclimatization or sham acclimatization. Before each cycle (measurement [M] 1 and 3) and a</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-16T23:54:25.078Z</modification><creation>2025-04-04T02:51:14.249Z</creation></dates><accession>S-EPMC11570677</accession><cross_references><pubmed>39552103</pubmed><doi>10.1002/brb3.70165</doi></cross_references></HashMap>